Annual Cash & Cash Equivalents
$232.40 K
+$142.30 K+157.94%
December 31, 2023
Summary
- As of February 12, 2025, INVO annual cash & cash equivalents is $232.40 thousand, with the most recent change of +$142.30 thousand (+157.94%) on December 31, 2023.
- During the last 3 years, INVO annual cash & cash equivalents has fallen by -$9.87 million (-97.70%).
Performance
INVO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$471.59 K
-$471.31 K-49.99%
September 30, 2024
Summary
- As of February 12, 2025, INVO quarterly cash and cash equivalents is $471.59 thousand, with the most recent change of -$471.31 thousand (-49.99%) on September 30, 2024.
- Over the past year, INVO quarterly cash and cash equivalents has dropped by -$3509.00 (-0.74%).
Performance
INVO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INVO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +157.9% | -0.7% |
| 3 y3 years | -97.7% | -87.7% |
| 5 y5 years | +9.5% | -87.7% |
INVO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.9% | -61.2% | -91.7% | -80.9% |
| 5 y | 5-year | -97.7% | -61.2% | -95.3% | -80.9% |
| alltime | all time | -97.7% | -99.8% | -95.3% | -100.0% |
INVO Bioscience Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $471.59 K(-50.0%) |
| Jun 2024 | - | $942.90 K(+98.5%) |
| Mar 2024 | - | $475.10 K(+104.4%) |
| Dec 2023 | $232.40 K(+157.9%) | $232.40 K(-78.0%) |
| Sep 2023 | - | $1.06 M(+838.2%) |
| Jun 2023 | - | $112.50 K(-94.9%) |
| Mar 2023 | - | $2.19 M(+2328.6%) |
| Dec 2022 | $90.10 K(-98.4%) | $90.10 K(-68.5%) |
| Sep 2022 | - | $285.70 K(-85.4%) |
| Jun 2022 | - | $1.96 M(-48.9%) |
| Mar 2022 | - | $3.84 M(-32.5%) |
| Dec 2021 | $5.68 M(-43.7%) | $5.68 M(+20.6%) |
| Sep 2021 | - | $4.71 M(-29.1%) |
| Jun 2021 | - | $6.64 M(-21.1%) |
| Mar 2021 | - | $8.42 M(-16.6%) |
| Dec 2020 | $10.10 M(+715.3%) | $10.10 M(+1011.7%) |
| Sep 2020 | - | $908.30 K(-39.6%) |
| Jun 2020 | - | $1.50 M(+329.7%) |
| Mar 2020 | - | $350.00 K(-71.7%) |
| Dec 2019 | $1.24 M(+483.7%) | $1.24 M(-38.4%) |
| Sep 2019 | - | $2.01 M(-24.5%) |
| Jun 2019 | - | $2.66 M(-12.9%) |
| Mar 2019 | - | $3.06 M(+1340.9%) |
| Dec 2018 | $212.20 K(+722.5%) | $212.20 K(-61.3%) |
| Sep 2018 | - | $548.00 K(-23.9%) |
| Jun 2018 | - | $720.30 K(+1934.7%) |
| Mar 2018 | - | $35.40 K(+37.2%) |
| Dec 2017 | $25.80 K | $25.80 K(-26.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $35.30 K(+95.0%) |
| Jun 2017 | - | $18.10 K(-54.3%) |
| Mar 2017 | - | $39.60 K(-74.0%) |
| Dec 2016 | $152.40 K(-69.0%) | $152.40 K(-41.1%) |
| Sep 2016 | - | $258.60 K(-20.1%) |
| Jun 2016 | - | $323.60 K(-23.6%) |
| Mar 2016 | - | $423.30 K(-14.0%) |
| Dec 2015 | $492.00 K(+2545.2%) | $492.00 K(>+9900.0%) |
| Dec 2014 | $18.60 K(+3.3%) | - |
| Dec 2013 | $18.00 K(+150.0%) | - |
| Dec 2012 | $7200.00(+1700.0%) | - |
| Dec 2011 | $400.00(-96.8%) | $400.00(-81.8%) |
| Sep 2011 | - | $2200.00(-77.3%) |
| Jun 2011 | - | $9700.00(+86.5%) |
| Mar 2011 | - | $5200.00(-58.4%) |
| Dec 2010 | $12.50 K(-84.2%) | $12.50 K(+31.6%) |
| Sep 2010 | - | $9500.00(+1483.3%) |
| Jun 2010 | - | $600.00(-83.8%) |
| Mar 2010 | - | $3700.00(-95.3%) |
| Dec 2009 | $79.10 K(+403.8%) | $79.10 K(-59.3%) |
| Sep 2009 | - | $194.40 K(>+9900.0%) |
| Jun 2009 | - | $100.00(-99.0%) |
| Mar 2009 | - | $9800.00(-37.6%) |
| Dec 2008 | $15.70 K(+241.3%) | $15.70 K(+3825.0%) |
| Sep 2008 | - | $400.00(-20.0%) |
| Jun 2008 | - | $500.00(-16.7%) |
| Mar 2008 | - | $600.00(-87.0%) |
| Dec 2007 | $4600.00(-66.7%) | $4600.00 |
| Dec 2006 | $13.80 K | - |
FAQ
- What is INVO Bioscience annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for INVO Bioscience?
- What is INVO Bioscience annual cash & cash equivalents year-on-year change?
- What is INVO Bioscience quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for INVO Bioscience?
- What is INVO Bioscience quarterly cash and cash equivalents year-on-year change?
What is INVO Bioscience annual cash & cash equivalents?
The current annual cash & cash equivalents of INVO is $232.40 K
What is the all time high annual cash & cash equivalents for INVO Bioscience?
INVO Bioscience all-time high annual cash & cash equivalents is $10.10 M
What is INVO Bioscience annual cash & cash equivalents year-on-year change?
Over the past year, INVO annual cash & cash equivalents has changed by +$142.30 K (+157.94%)
What is INVO Bioscience quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INVO is $471.59 K
What is the all time high quarterly cash and cash equivalents for INVO Bioscience?
INVO Bioscience all-time high quarterly cash and cash equivalents is $10.10 M
What is INVO Bioscience quarterly cash and cash equivalents year-on-year change?
Over the past year, INVO quarterly cash and cash equivalents has changed by -$3509.00 (-0.74%)